Shanghai, China

Ainur Abula

This inventor holds 1 USPTO granted patent. Top assignee: Water Bear Health Technology (Nantong) Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ainur Abula. Retrieved from https://idiyas.com/inventor/ainur-abula

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ainur Abula: Microfluidic Innovation for Single-Cell Analysis.

Introduction

Ainur Abula is an inventor associated with Shanghai, China. Her patent work focuses on microfluidic technology for separating circulating tumor cells and analyzing proteins at the single-cell level.

Latest Patents

Abula is named on 1 patent: “Microfluidic Chip and Manufacture Method Thereof, and Cell Separation and Single-Cell Western Blotting Method.” The invention describes a chip with a first unit that separates circulating tumor cells from a cell sample and a second unit that captures individual cells and lyses them in a closed environment. A gel layer in the second unit enables proteins from lysed cells to bind with antibodies.

The patent also describes a method for cell separation and western blotting using the chip, as well as a manufacturing process involving interlayers, a basal layer, and bonded separation and single-cell capture units. Together, these features support the capture and analysis of individual circulating tumor cells.

Career Highlights

Abula’s listed patent is associated with Water Bear Health Technology (Nantong) Co., Ltd. The invention addresses a technical challenge in biomedical analysis by integrating cell separation, single-cell capture, lysis, and protein detection into a microfluidic platform.

Collaborations

Ting Zhang and Haiyang Xie are identified as Abula’s coworkers. The available information does not specify their roles in the patent or the extent of their collaboration.

Conclusion

Ainur Abula’s patent presents a microfluidic approach that combines circulating tumor cell separation with single-cell western blotting, contributing an integrated tool for cellular and protein analysis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…